DE60025648D1 - Peptide mit antiangiogener aktivität - Google Patents

Peptide mit antiangiogener aktivität

Info

Publication number
DE60025648D1
DE60025648D1 DE60025648T DE60025648T DE60025648D1 DE 60025648 D1 DE60025648 D1 DE 60025648D1 DE 60025648 T DE60025648 T DE 60025648T DE 60025648 T DE60025648 T DE 60025648T DE 60025648 D1 DE60025648 D1 DE 60025648D1
Authority
DE
Germany
Prior art keywords
peptides
antiangiogenic activity
angiogenesis
inhibiting
xaa11
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60025648T
Other languages
English (en)
Other versions
DE60025648T2 (de
Inventor
Fortuna Haviv
Jack Henkin
Michael F Bradley
M Kalvin
J Schneider
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Laboratories
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Publication of DE60025648D1 publication Critical patent/DE60025648D1/de
Application granted granted Critical
Publication of DE60025648T2 publication Critical patent/DE60025648T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
DE60025648T 1999-11-22 2000-11-22 Peptide mit antiangiogener aktivität Expired - Fee Related DE60025648T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US44722599A 1999-11-22 1999-11-22
US447225 1999-11-22
US70903400A 2000-11-08 2000-11-08
US709034 2000-11-08
PCT/US2000/032217 WO2001038347A2 (en) 1999-11-22 2000-11-22 Peptides having antiangiogenic activity

Publications (2)

Publication Number Publication Date
DE60025648D1 true DE60025648D1 (de) 2006-04-06
DE60025648T2 DE60025648T2 (de) 2006-09-14

Family

ID=27034912

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60025648T Expired - Fee Related DE60025648T2 (de) 1999-11-22 2000-11-22 Peptide mit antiangiogener aktivität

Country Status (12)

Country Link
EP (1) EP1232183B1 (de)
JP (1) JP2003530313A (de)
AT (1) ATE316102T1 (de)
CA (1) CA2391386A1 (de)
CY (1) CY1106074T1 (de)
DE (1) DE60025648T2 (de)
DK (1) DK1232183T3 (de)
ES (1) ES2256071T3 (de)
HK (1) HK1050012B (de)
MX (1) MXPA02005150A (de)
PT (1) PT1232183E (de)
WO (1) WO2001038347A2 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020183242A1 (en) * 2001-04-11 2002-12-05 Jack Henkin Peptide antiangiogenic drugs
US20030125260A1 (en) * 2001-10-31 2003-07-03 Fortuna Haviv Tetra-and pentapeptides having antiangiogenic activity
US7169888B2 (en) 2001-10-31 2007-01-30 Abbott Laboratories Tetra-, penta-, hexa- and heptapeptides having antiangiogenic activity
US7001984B2 (en) 2001-10-31 2006-02-21 Abbott Laboratories Di-, tri-, and tetra-peptides having antiangiogenic activity
US7037897B2 (en) 2001-10-31 2006-05-02 Abbott Laboratories TRI-, TETRA-, and penta-peptides having antiangiogenic activity
US20030119746A1 (en) * 2001-10-31 2003-06-26 Fortuna Haviv Hepta-and octapeptides having antiangiogenic activity
US7122625B2 (en) 2001-10-31 2006-10-17 Abbott Laboratories Hexa-, hepta-, and octapeptides having antiangiogenic activity
US20030125259A1 (en) 2001-10-31 2003-07-03 Fortuna Haviv Octa- and nonapeptides having antiangiogenic activity
US7067490B2 (en) 2001-10-31 2006-06-27 Abbott Laboratories Hepta-, Octa-and nonapeptides having antiangiogenic activity
US20030228365A1 (en) * 2002-06-07 2003-12-11 Fortuna Haviv Pharmaceutical formulation
KR101373140B1 (ko) 2005-03-03 2014-03-12 씨오브이엑스 테크놀로지스 아일랜드 리미티드 항-혈관형성 화합물

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5200397A (en) * 1990-02-22 1993-04-06 W. R. Grace & Co.-Conn. Use of peptide analogs of thrombospondin for the inhibition of angiogenic activity
DK0918795T3 (da) * 1997-03-17 2005-03-14 Abbott Lab Antiangiogene lægemidler til behandling af cancer, arthritis og retinopati

Also Published As

Publication number Publication date
WO2001038347A2 (en) 2001-05-31
PT1232183E (pt) 2006-06-30
WO2001038347A3 (en) 2001-11-29
EP1232183A2 (de) 2002-08-21
ES2256071T3 (es) 2006-07-16
CA2391386A1 (en) 2001-05-31
ATE316102T1 (de) 2006-02-15
MXPA02005150A (es) 2003-01-28
DE60025648T2 (de) 2006-09-14
HK1050012B (zh) 2006-09-08
CY1106074T1 (el) 2011-06-08
EP1232183B1 (de) 2006-01-18
JP2003530313A (ja) 2003-10-14
DK1232183T3 (da) 2006-05-29
HK1050012A1 (en) 2003-06-06

Similar Documents

Publication Publication Date Title
ATE293618T1 (de) 4, 5, 6, 7-tetrahydroindazolderivate als antitumormittel
DE60010098D1 (de) 28-epirapaloge
DE69708120D1 (de) Laser-absorbierende, lichtbleichbare zusammensetzungen
ATE396204T1 (de) Peptide als antiangiogene arzneimittel
ATE241597T1 (de) Geruchsmaskierte dimethylsulfid-zusammensetzung
ATE316102T1 (de) Peptide mit antiangiogener aktivität
ATE283278T1 (de) Peptid derivate
DE60025385D1 (de) 2,4-diaminopyrimidinderivate als immunosuppressiva
DE60008524D1 (de) Furanonderivate als inhibitoren von cathepsin s
DE50006919D1 (de) Femurschlitten
DE69931821D1 (de) Wärmehärtbare pulverlack-zusammensetzung
DE69729302T2 (de) Illudin analoge verwendet als antitumormittel
NO20041300L (no) Flavanolignanpreparater med okt loselighet
DK0882066T3 (da) Peptidderivater
DE50011908D1 (de) 16-hydroxyestratriene als selektiv wirksame estrogene
DE50010821D1 (de) Abklappbarer wischarm
DK199901339A (da) Sok eller strømpe til terapeutisk brug
BR0010934A (pt) Peptìdeos n-alquilados possuindo atividade antiangiogênica
ATE385805T1 (de) Neue peptide
DK0948525T3 (da) Cyclopeptidderivater
NO20013933D0 (no) Peptider
FI965181A (fi) Polyalkoholi-peptidijohdannaiset
DE10083673T1 (de) Radaufhängung
IT1313570B1 (it) Procedimento di liofilizzazione in solventi non acquosi.
DE60036651D1 (de) Sericin enthaltende Nagelzusammensetzung

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee